Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis

No meta-analysis has analyzed the safety and efficacy of rivoglitazone in type-2 diabetes (T2DM). We undertook this meta-analysis to address this knowledge gap. Electronic databases were searched for RCTs involving T2DM patients receiving rivoglitazone in the intervention arm, and placebo/active com...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Kadian, Jyoti, Maisnam, Indira, Kumar, Ashok, Bhattacharya, Saptarshi, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586552/
https://www.ncbi.nlm.nih.gov/pubmed/37867986
http://dx.doi.org/10.4103/ijem.ijem_17_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586552/
https://www.ncbi.nlm.nih.gov/pubmed/37867986
http://dx.doi.org/10.4103/ijem.ijem_17_23

Ejemplares similares